Eli Lilly & Co. (NYSE:LLY)

generic drugs

4 Pharmaceutical Stocks to Buy for Outperformance in 2015

It is a nice change sometimes when the prognosticators on Wall Street, who tend to follow each other's lead, are not only right, but investors come out on top. Almost ...
Read Full Story »
Pills

4 Top Pharmaceutical Stocks to Buy for Market Safety

Tuesday's big downward move reminded everybody that while things look encouraging for the stock market long term, momentum stocks tend to get absolutely eviscerated when a big volatility jump helps ...
Read Full Story »
Pfizer logo

Jefferies 4 Top Pharmaceutical Stocks to Buy

With the stock market hitting all-time highs, many investors are starting to wonder which sectors still hold value. Although seeming rich, the market continues climbing a wall of worry to ...
Read Full Story »
Pills

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the costs of some of the drugs on the market today. ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Apple, Barrick Gold, Corning, Groupon, Peabody, SolarCity and More

Stocks were mixed on Thursday after two days of losses. While sell-offs have been sharp and out of the blue, investors have time and again shown that they will buy stocks on ...
Read Full Story »
Pills

5 Top Pharmaceutical Stock Picks for 2015

After an outstanding 2014, the health care sector could be primed for yet another solid performance in 2015. While many analysts on Wall Street are very positive on the group, ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: ARIAD, FedEx, Genpact, Suncor, Travelers, UPS and More

Stocks were trying to post a recovery on Thursday morning on the heels of three days worth of energy-related selling. Despite a relatively harsh drop, investors have proven over and ...
Read Full Story »
135093244

The Best Stocks of 2014 Part 1: Materials, Consumer, Health, Industrials

Stocks have enjoyed yet another wonderful year in 2014, and the bull market is now more than five and a half years old. With the S&P 500 index up almost ...
Read Full Story »
biotech

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

One sad thing for almost every citizen in the United States is that at one point almost all of us will either have cancer or have a friend or relative ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Eli Lilly, Enphase, Lululemon, SodaStream, Yelp and More

Stocks were lower on Thursday after weak overseas trading. Investors are braced for Friday's key unemployment and payrolls report, and they are still looking for upside from their investment funds. ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Stocks were firm on Tuesday morning during a shortened week that actually will be full of economic reports. 24/7 Wall St. reviews dozens of analyst research reports each morning of ...
Read Full Story »
470431521

The Highest-Yielding Dividends That Are Safe to Hold

Dividend payments by S&P 500 companies reached an all-time high last year, totaling some $330.8 billion, according to FactSet. As of this March, 418 of the 500 companies in the ...
Read Full Story »
down market

Biotech: The Poster Child for Market Volatility in 2014

When 2014 began, no one promised the stock market would rise in a nice, smooth regal sort of way. Boy, were they right. Stocks have been subject to intense bursts ...
Read Full Story »
139716013

UPS Joins Others Down in the Dumps

United Parcel Service Inc. (NYSE: UPS) reported first-quarter 2014 results before markets opened Thursday, and no surprise, winter weather was its theme of the day. And no surprise either that ...
Read Full Story »
$5

Expired Patents Take a Bite out of Eli Lilly Results

Eli Lilly & Co. (NYSE: LLY) reported first-quarter 2014 results before markets opened Thursday. The pharmaceutical giant posted adjusted diluted earnings per share (EPS) of $0.68 on revenues of $4.68 ...
Read Full Story »